Research reveals a microneedle-based glucose sensor for real-time monitoring of interstitial fluid glucose levels, indicating its potential in home care applications.
The objective of this work is to develop a selective glucose sensor for real-time in vivo monitoring of interstitial fluid (ISF) glucose levels, addressing challenges of interference from other biomolecules. A microneedle (MN) patch was employed for ISF extraction, while a 2D tellurene (Te)-based glucose oxidase (GOX) GOX/Te/carbon cloth (CC) electrode served as the sensing element for electrochemical measurements. The sensor exhibited a low detection limit (LOD) of 0.357 μM, and a sensitivity of 0.10378 mA μM-1 cm-2. In vivo studies in an animal model demonstrated an average glucose concentration of 5.05 mM with a rapid response time of ∼95 s. Importantly, the electrochemical measurements showed a strong correlation with commercial glucometer readings, confirming accuracy and reliability. This study highlights the potential of the proposed sensor for real-time in vivo glucose monitoring, paving the way for future home care diabetes management devices.
No takes yet. Share an insight, caveat, or question.
Basumatary et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: